- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05298956
Brain Substrates for Cardiovascular Stress Physiology
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Waco, Texas, United States, 76798
- Recruiting
- Annie T. Ginty
-
Contact:
- Annie T. Ginty, PhD
- Phone Number: 254-710-2236
- Email: annie_ginty@baylor.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
18-30 years old
Exclusion Criteria:
History of a diagnosed chronic medical or neurological disorder Current pregnancy Current illness or infection (e.g., cold, flu) Any condition that would prohibit them from engaging in physical exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Sham
Participants will receive sham laser to the right forehead.
|
Sham Comparator: Participants will receive 8 counts of 60 seconds of the same laser to the right forehead, however the laser power will be turned off and will be 0 Watts. Transcranial infrared laser stimulation: Participants will receive 8 counts of 60 seconds of transcranial infrared laser stimulation to the right forehead. The wavelength will be 1064 nm and the laser power will be 3.4 Watts. |
|
Active Comparator: Transcranial infrared laser stimulation
Participants will receive transcranial infrared laser stimulation to the right forehead.
|
Sham Comparator: Participants will receive 8 counts of 60 seconds of the same laser to the right forehead, however the laser power will be turned off and will be 0 Watts. Transcranial infrared laser stimulation: Participants will receive 8 counts of 60 seconds of transcranial infrared laser stimulation to the right forehead. The wavelength will be 1064 nm and the laser power will be 3.4 Watts. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen consumption in response to acute psychological stress
Time Frame: Immediately following intervention (up to 60 minutes)
|
This measurement takes into account oxygen consumption at baseline and during the stress task.
|
Immediately following intervention (up to 60 minutes)
|
|
Heart rate in response to acute psychological stress
Time Frame: Immediately following intervention (up to 60 minutes)
|
This measurement takes into account heart rate at baseline and during the stress task.
|
Immediately following intervention (up to 60 minutes)
|
|
Additional heart rate in response to acute psychological stress
Time Frame: Immediately following intervention (up to 60 minutes)
|
This measurement takes into account additional heart rate at baseline and during stress.
|
Immediately following intervention (up to 60 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived stress
Time Frame: Immediately following intervention (up to 60 minutes)
|
Ratings of perceived stressfulness (1 = not at all stressful, 7 = very stressful) of the acute psychological stress task
|
Immediately following intervention (up to 60 minutes)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1437574
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.